The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Projected 30-day out-of-pocket and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
 
Arjun Gupta
No Relationships to Disclose
 
Naveen Premnath
No Relationships to Disclose
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Array BioPharma; AstraZeneca/MedImmune; Cancer Commons; Ipsen
Research Funding - Agios (Inst); ArQule (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmuneSensor Therapeutics (Inst); MedImmune (Inst); Merck Serono (Inst); Sillajen (Inst); Tolero Pharmaceuticals (Inst)
 
Rohan Khera
No Relationships to Disclose
 
Stacie Dusetzina
Other Relationship - Arnold Ventures (Inst); Institute for Clinical and Economic Review; Leukemia and Lymphoma Society (Inst); National Academy of State Health Policy; The Commonwealth Fund (Inst); West Health